GET FREE CONSULTATION!
+256 704 292188
The World Health Organization (WHO) issued a medical product alert on falsified semaglutides, the type of medicines that are used for treatment of type 2 diabetes and obesity in some countries. The alert addresses 3 falsified batches of product of semaglutide class of medicines (of specific brand Ozempic), which have been detected in Brazil in October 2023,…
By Malik Jjingo In efforts to end the spread of HIV by 2030, researchers have called upon the government to support the increased uptake of new innovations that have been proved to be effective in protecting people against contracting the HIV virus. Preventive measures such us PrEP medicine (Pre-exposure prophylaxis) and Post Exposure Prophylaxis (PEP),…
AVAC welcomes the groundbreaking results of the PURPOSE 1 HIV prevention study among adolescent girls and young women in South Africa and Uganda. Preliminary safety and efficacy results were reported today by Gilead Sciences, the developer of the lenacapavir, one of the HIV prevention drugs that was being studied in the trial. An independent data…